As of 2025-02-17, the Relative Valuation of Halozyme Therapeutics Inc (HALO) is 119.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.29 USD, the upside of Halozyme Therapeutics Inc based on Relative Valuation is 104.9%.
The range of the Relative Valuation is 87.74 - 154.54 USD.
Range | Selected | |
Trailing P/E multiples | 38.2x - 50.1x | 44.2x |
Forward P/E multiples | 32.0x - 42.9x | 37.4x |
Fair Price | 87.74 - 154.54 | 119.43 |
Upside | 50.5% - 165.1% | 104.9% |
Date | P/E |
2025-02-14 | 18.90 |
2025-02-13 | 19.00 |
2025-02-12 | 18.84 |
2025-02-11 | 18.59 |
2025-02-10 | 18.59 |
2025-02-07 | 18.51 |
2025-02-06 | 18.78 |
2025-02-05 | 18.68 |
2025-02-04 | 18.40 |
2025-02-03 | 18.24 |
2025-01-31 | 18.36 |
2025-01-30 | 18.29 |
2025-01-29 | 18.10 |
2025-01-28 | 18.15 |
2025-01-27 | 18.11 |
2025-01-24 | 18.08 |
2025-01-23 | 18.03 |
2025-01-22 | 17.92 |
2025-01-21 | 18.13 |
2025-01-17 | 17.77 |
2025-01-16 | 17.95 |
2025-01-15 | 17.67 |
2025-01-14 | 17.45 |
2025-01-13 | 17.55 |
2025-01-10 | 17.12 |
2025-01-08 | 17.43 |
2025-01-07 | 16.59 |
2025-01-06 | 16.37 |
2025-01-03 | 15.48 |
2025-01-02 | 15.56 |
2024-12-31 | 15.50 |
2024-12-30 | 15.56 |
2024-12-27 | 15.60 |
2024-12-26 | 15.57 |
2024-12-24 | 15.41 |
2024-12-23 | 15.29 |
2024-12-20 | 15.22 |
2024-12-19 | 15.34 |
2024-12-18 | 15.18 |
2024-12-17 | 15.76 |
2024-12-16 | 15.57 |
2024-12-13 | 15.56 |
2024-12-12 | 15.51 |
2024-12-11 | 15.36 |
2024-12-10 | 15.90 |
2024-12-09 | 15.90 |
2024-12-06 | 15.69 |
2024-12-05 | 15.58 |
2024-12-04 | 15.76 |
2024-12-03 | 15.72 |